These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8906877)

  • 21. Binding of the bovine basic pancreatic trypsin inhibitor (Kunitz) to human Glu1-, Lys77-, Val442-, and Val561-plasmin: a comparative study.
    Ascenzi P; Amiconi G; Bolognesi M; Menegatti E; Guarneri M
    Biochim Biophys Acta; 1990 Aug; 1040(1):134-6. PubMed ID: 2143086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-resolution structure of bovine pancreatic trypsin inhibitor with altered binding loop sequence.
    Czapinska H; Otlewski J; Krzywda S; Sheldrick GM; Jaskólski M
    J Mol Biol; 2000 Feb; 295(5):1237-49. PubMed ID: 10653700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disulfide engineering of human Kunitz-type serine protease inhibitors enhances proteolytic stability and target affinity toward mesotrypsin.
    Cohen I; Coban M; Shahar A; Sankaran B; Hockla A; Lacham S; Caulfield TR; Radisky ES; Papo N
    J Biol Chem; 2019 Mar; 294(13):5105-5120. PubMed ID: 30700553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a residue critical for maintaining the functional conformation of BPTI.
    Hanson WM; Beeser SA; Oas TG; Goldenberg DP
    J Mol Biol; 2003 Oct; 333(2):425-41. PubMed ID: 14529627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Folding of bovine pancreatic trypsin inhibitor (BPTI) variants in which almost half the residues are alanine.
    Kuroda Y; Kim PS
    J Mol Biol; 2000 May; 298(3):493-501. PubMed ID: 10772865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Free energy calculations show that acidic P1 variants undergo large pKa shifts upon binding to trypsin.
    Brandsdal BO; Smalås AO; Aqvist J
    Proteins; 2006 Aug; 64(3):740-8. PubMed ID: 16752417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of the Kunitz soybean trypsin inhibitor with bovine trypsin. Evidence for an an acy-enzyme intermediate during complexation.
    Huang JS; Liener IE
    Biochemistry; 1977 May; 16(11):2474-8. PubMed ID: 16647
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of trypsin inhibitor of a peptide-protein nature on kallikreins from human and rabbit blood stream].
    Paskhina TS; Krinskaia AV; Zykova VP
    Biokhimiia; 1975; 40(2):302-9. PubMed ID: 1081887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An electrospray ionization mass spectrometry investigation of 1-anilino-8-naphthalene-sulfonate (ANS) binding to proteins.
    Ray SS; Singh SK; Balaram P
    J Am Soc Mass Spectrom; 2001 Apr; 12(4):428-38. PubMed ID: 11322189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Native-like interactions favored in the unfolded bovine pancreatic trypsin inhibitor have different roles in folding.
    Li R; Battiste JL; Woodward C
    Biochemistry; 2002 Feb; 41(7):2246-53. PubMed ID: 11841216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of complexes formed by a crustacean and a vertebrate trypsin with bovine pancreatic trypsin inhibitor - the key to achieving extreme stability?
    Molnár T; Vörös J; Szeder B; Takáts K; Kardos J; Katona G; Gráf L
    FEBS J; 2013 Nov; 280(22):5750-63. PubMed ID: 24034223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crystal structures of rat anionic trypsin complexed with the protein inhibitors APPI and BPTI.
    Perona JJ; Tsu CA; Craik CS; Fletterick RJ
    J Mol Biol; 1993 Apr; 230(3):919-33. PubMed ID: 7683059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective bridging of bis-cysteinyl residues by arsonous acid derivatives as an approach to the characterization of protein tertiary structures and folding pathways by mass spectrometry.
    Happersberger HP; Przybylski M; Glocker MO
    Anal Biochem; 1998 Nov; 264(2):237-50. PubMed ID: 9866689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformation of native, reduced and [5-55]Ala bovine pancreatic trypsin inhibitor in the gas phase.
    Nesatiy V; Chen YL; Collings BA; Douglas DJ
    Rapid Commun Mass Spectrom; 1998; 12(1):40-4. PubMed ID: 9450353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of proteinase complex formation with alpha 2-macroglobulin. Three modes of trypsin binding.
    Sottrup-Jensen L; Petersen TE; Magnusson S
    FEBS Lett; 1981 Jun; 128(1):127-32. PubMed ID: 6168492
    [No Abstract]   [Full Text] [Related]  

  • 36. The P(2)' residue is a key determinant of mesotrypsin specificity: engineering a high-affinity inhibitor with anticancer activity.
    Salameh MA; Soares AS; Hockla A; Radisky DC; Radisky ES
    Biochem J; 2011 Nov; 440(1):95-105. PubMed ID: 21806544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thermodynamics of single peptide bond cleavage in bovine pancreatic trypsin inhibitor (BPTI).
    Buczek O; Krowarsch D; Otlewski J
    Protein Sci; 2002 Apr; 11(4):924-32. PubMed ID: 11910035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complex formation of guanidinated bovine trypsin inhibitor (Kunitz) with trypsin, chymotrypsin and trypsinogen as studied by the spin-label technique.
    Wenzel HR; Tschesche H; von Goldammer E; Netzelmann U
    FEBS Lett; 1982 Apr; 140(1):53-7. PubMed ID: 6282626
    [No Abstract]   [Full Text] [Related]  

  • 39. On the reaction of acetamidomethanol with native and reduced bovine pancreatic trypsin inhibtor (Kunitz inhibitor).
    Rocchi R; Benassi CA; Tomatis R; Ferroni R; Menegatti E
    Int J Pept Protein Res; 1976; 8(2):167-75. PubMed ID: 1270188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrophobic interactions control zymogen activation in the trypsin family of serine proteases.
    Hedstrom L; Lin TY; Fast W
    Biochemistry; 1996 Apr; 35(14):4515-23. PubMed ID: 8605201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.